CHARACTERIZATION OF THE BINDING-SITES FOR THE NOVEL ANTI-HYPERGLYCEMIC DRUG, REPAGLINIDE

Authors
FUHLENDORFF J SHYMKO R CARR RD KOFOD H
Citation
J. Fuhlendorff et al., CHARACTERIZATION OF THE BINDING-SITES FOR THE NOVEL ANTI-HYPERGLYCEMIC DRUG, REPAGLINIDE, Diabetes, 44, 1995, pp. 231-231
Citations number
NO
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
Journal title
Diabetes → ACNP
ISSN journal
00121797
Volume
44
Year of publication
1995
Supplement
1
Pages
231 - 231
Database
ISI
SICI code
0012-1797(1995)44:<231:COTBFT>2.0.ZU;2-L